Investors in Luxembourg

Amethis is an investment fund manager dedicated to the African continent, with an investment capacity exceeding €650m. Amethis brings growth capital to promising midcap champions in a diversity of sectors throughout the African continent. As an active shareholder, Amethis offers key support and expertise through its international network, its opportunities of external growth and its value-added governance.

M80 is a private equity firm specializing in middle market, later stage, mature, buyout, and growth capital investments. The firm primarily invests in the consumer, healthcare, business services and manufacturing sector. It does not invest in real estate, R&D based life sciences, and pre-commercial technology companies. It typically invests in companies in Belgium, the Netherlands, Luxembourg and France. The firm makes equity investments between €10 million ($12.05 million) and €60 million ($72.28 million) in companies with sales values between €25 million ($30.12 million) and €300 million ($361.4 million), an EBITDA between €5 million ($6.02 million) and €30 million ($36.14 million) and an enterprise value between €25 million ($30.12 million) and €250 million ($301.17 million). The firm prefers to have a majority stake in portfolio companies. M80 was founded in 2018 and is based in Brussels, Belgium.

Apheon is a private equity firm specializing in buyout, International expansion, add-on acquisitions, carve-out and industry consolidation investments in lower middle market and mature companies. The firm prefers to invest in niche industrials, healthcare, consumer, services and media. It seeks to invest in Europe, Andorra, Gibraltar, Luxembourg, Netherlands, Iberia, Spain, Portugal, Germany, Switzerland, Italy, Benelux, and France. It typically invests between €10 million ($11.71 million) and €75 million ($87.86 million) in companies having EBITDA between €10 million ($11.71 million) and €60 million ($70.28 million), Enterprise Value upto €300 million ($351.44 million) and turnover between €20 million ($23.42 million) and €100 million ($117.14 million). The firm prefers to take majority stake in portfolio companies. Apheon was founded in 2005 and is headquartered in Luxembourg City, Luxembourg, with additional offices in Europe.

Astorg is a global private equity firm with €13 billion of assets under management. With offices in London, Paris, New York, Milan, Frankfurt and Luxembourg, Astorg's investment team comprises of 66 professionals. Creating value starts with a clear investment strategy, supported by a disciplined investment process. Our investment process ensures we fully understand the strength of the strategic fundamentals of the companies we invest in, and chart the right path for future value creation. We get this understanding from our ability to carefully listen to founders and management teams of businesses we are interested in, and from the uncompromising market research that we conduct in parallel. We can then move quickly, thanks to simple, local decision making. The success of the Astorg process is shown by the long-term value we have created over the last 20 years. And it’s only when we understand what the goals and ambitions of management teams are that we act. We want to invest alongside business leaders driven by a long-term vision and aware of the high cost of capital. Our involvement as shareholders is to ensure that the right human resources are deployed, that capital employment is optimised and that a clear strategic roadmap is executed. We concentrate on deals where we can develop a competitive advantage – this can come from our in-depth knowledge of a sector or industry or our ability to deliver a complex transaction. And by focusing on a limited number of companies per fund we can: Share our experience to optimise key performance drivers Identify, unlock and execute complementary acquisitionsActively participate in key strategic decisionsInitiate and support performance improvement initiatives Support the management team as needed

Hayfin Capital Management is a leading alternative asset management firm. Since the firm’s founding in 2009, Hayfin has invested over €46.5 billion of capital through its private markets strategies, in over 500 companies. Hayfin focuses on delivering best-in-class risk-adjusted returns for its investors across four strategies: Direct Lending, Special Opportunities, High-Yield Credit and Private Equity Solutions. Hayfin has a diverse international team of over 200 experienced industry professionals with offices globally, including headquarters in London and offices in Chicago, Dubai, Frankfurt, Luxembourg, Madrid, Milan, Munich, New York, Paris, Stockholm, San Diego and Tokyo.

Balnord is a venture capital firm specializing in seed/startup, pre-seed to exist stage investments. The firm invest in in deep tech and frontier tech projects in sectors such as supply chain, healthcare, space tech, data-driven software and dual-use technologies. The firm invest in Poland and the Baltic Sea basin region based companies. The firm prefers to invest between 500k euro ($0.58 million) and 2 million euro ($2.35 million). Balnord was founded in 2024 and is based in Luxembourg.

CEECAT Capital advises funds investing in small and mid market companies in Emerging Europe and Central Asia. Our investors include global financial institutions, pension funds, endowments and family offices. Our mission is to create long-term value for our investors by investing in and promoting the growth of our portfolio companies. We seek to partner with top management teams to promote socially responsible growth and best in class corporate governance. We are passionate about helping our portfolio companies become regional champions. The team operates out of six offices: London, Luxembourg, Bucharest, Belgrade, Istanbul, and Almaty.

Eurazeo is a leading global investment company, based in Paris and Luxembourg, New York, Shanghai and Sao Paolo, with more than € 16 billion in diversified assets, including more than € 10 billion on behalf of third parties. Its mission is to detect, accelerate and enhance the transformation potential of the companies in which it invests. Eurazeo is present in various private equity segments through its five investment hubs - Eurazeo Capital, Eurazeo Croissance, Eurazeo PME, Eurazeo Patrimoine, Eurazeo Brands - and through Idinvest's three business hubs: innovation capital, private debt and dedicated Mandates and Funds. Its institutional and family shareholders, its solid financial structure without structural debt and its flexible investment horizon allow it to support companies over the long term.

MTIP AG is a private equity firm specializing in later stage, emerging growth and growth capital investments. The firm seeks to invest in the healthcare, medical devices & technology, diagnostics, tech-enabled healthcare services and connected medical devices as well as digital health. The firm prefer to invest in European companies including Switzerland, UK and Israel. It prefers to invest up to €25 million ($29.89 million). It prefers to take a significant minority stake of more than 10% and a seat on the board of the investee companies. The firm prefer to exit in less than 5 years. The firm also considers follow-up investments. MTIP AG was founded in 2014 and is based in Basel, Switzerland with an additional office in Luxembourg.

Satgana is an early-stage Climate Tech Venture Capital firm on a mission to invest in the next generation of planet-positive startups building the Future of Earth. We are global collective, passionate about taking climate action.As of November 2024, we count 19 portfolio startups spanning 11 countries across Europe and Africa.Satgana is a proud B Corp.This is the decade to build the world we want 🌱Join the journey at satgana.com

We invest in early-stage game-changing technology companies in angel rounds, series seed and pre-series A. VERSO X has a proprietary model for investing: - $50,000 for 5.00% post-money - 5x warrants or $250,000 - lead investor in next equity or debt round VERSO X main selection criteria are: - visionary yet execution-focused founders - clear unit economics and business model - proprietary tech and IP VERSO X is ultimately: - supportive of founders and their personal success - focused on increasing support along the way - engaged to deliver business advisory

KOUROS SA is a venture capital firm specializing in startups investments. It seeks investments in companies doing business in renewable energy with focus on hydrogen production & carbon neutrality, Downstream & Midstream Gas & Power, Emerging energy sources, technology bricks for energy and Circular economy. The firm prefers to invest in Europe, North America, Africa and Mediterranean Bassin. KOUROS SA was founded in 2016 and is based Luxembourg City, Luxembourg with additional office in Paris, France.

LetterOne is an international investment business headquartered in Luxembourg. We invest our own capital in companies that we think have unrealised potential and where we believe our strategic involvement can improve their performance and build significant value. We are very selective about the sectors in which we invest. We only invest in sectors where we have developed deep industry expertise. As businesspeople we bring, sector experience, strategic expertise, and our own permanent capital, to those companies in which we choose to invest. We are long-term growth investors – with no fixed investment time horizons. We know that building a better performing business takes time and determination. People need energy, food retail, and technology. As demographics change, people are increasingly concerned about their health. They need energy to power homes and grow economies. Therefore, these sectors have longevity and opportunity. Many industries are in significant flux because of changes in society, demographics and technology. Companies around the world are transforming their operating models and deepening their relationships and knowledge of their consumers. Our vision is to build on our proven track record of successful investments to create one of the world's leading international investment businesses. We have successfully managed companies through volatile periods like these and will undoubtedly do so again. We are disciplined when it comes to the execution of strategy. We have an operational mindset. Our investments are focused on the Energy, Retail, Telecoms & Health sectors through our business units, L1 Energy, L1 Retail, L1 Technology and L1 Health. Our liquidity is managed by L1 Treasury.

Luxempart is an investment firm specializing in direct and fund of fund investments. The firm also makes secondary direct investments. Within direct investments, it specializes in PIPE and private equity investments in middle market, later stage, mature, emerging growth, late venture, mezzanine, buyouts, acquisitions and private investment in public equity, and growth capital for small and medium sized companies. Within Investment Funds, it specializes in venture capital, growth capital, secondary and buyouts funds. The firm seeks to invest in listed and non-listed companies. For direct investments, the firm does not target a specific sector, but prefers to invest in companies operating in energy, media, banks, and financial services & insurance, holding companies, credit agencies, insurance brokers, healthcare, retail, industrials, security, and telecommunications sectors. It seeks to invest in companies based in Europe including Grand Duchy of Luxembourg and nearby regions, Belux, France, Germany, Northern Italy, Belgium, Austria, and Switzerland for direct investments, and in Europe, USA and Europe for fund investments. For direct investments it typically invests between €25 million ($27.15 million) and €100 million ($108.61 million) in companies with a minimum EBITDA of €1 million ($1.31 million), target enterprise value between €10 million ($13.11 million) and €2000 million ($2622.02 million), and with a minimum target sales value of €15 million ($19.66 million). For Investment Funds, it usually invests between EUR 10 million ($10.85 million) and EUR 25 million (27.14 million) per fund. It aims to aid its portfolio companies to their IPO through financial aid. The firm seeks Board seats in its portfolio companies. It prefers to take majority stakes in companies but also takes active minority stakes. Luxempart was founded in 1988, and is based in Leudelange, Luxembourg with additional offices in Belgium, Germany, France and Italy.

Aquasourça is a group dedicated to the private equity business, headquartered in Luxembourg. With subsidiaries in Lyon and Brussels, the group is led by a team of 10 people and is 100% owned by its founder, Sophie Defforey. Intervening on own funds and without recourse to subscribers, we focus our attention on the thirty or so companies we support in Europe.

C5 Capital is a London-based venture capital and private equity firm specializing in investments within the cybersecurity, cloud infrastructure, and clean energy sectors. Established in 2014, the firm focuses on supporting companies that address critical global challenges, particularly in areas of national security, data protection, and environmental sustainability. C5 Capital emphasizes technology-driven industries, with a strong focus on cybersecurity, secure data platforms, and clean energy innovations. Beyond financial backing, the firm provides operational expertise, global networks, and strategic partnerships to help portfolio companies scale effectively. With offices in London, Washington, D.C., and Luxembourg, C5 Capital leverages its international presence to connect portfolio companies with key markets and partners.

Edify S.A. is a private equity and venture capital firm specializing in early stage, middle market, mezzanine, buyout, mature, growth capital, later stage, medium-sized companies and smaller companies at key stages. The firm considers investments in all sectors with focus on agriculture, mobility, Medium-sized manufacturing, B2B service. The firm does not invest in alcohol, tobacco, firearms, and explosive. The firm seeks to invest in French and European Small-medium companies. The firm typically invests between $20 million and $100 million in companies whose enterprise value is between $40 million and $250 million. It seeks to take majority stake in a comapny. The firm invests through its personal capital. It was formerly known as Somfy Participations and changed its name to Edify S.A. in October 2014. Edify S.A. was founded in 2014 and is based in Luxembourg, Luxembourg with an additional office in Geneva, Switzerland. Edify S.A.(BDL: EDIFY) operates independently of Somfy SA as of December 19, 2014.

Groupe ILP is an investment firm specializing in direct and fund of funds investments. Within direct investments it specializes in private equity and venture capital investments in seed/start-ups, early stage, mid venture, late venture, leveraged buyout, succession, turnaround, and growth capital investments. The firm typically invests in small and medium size companies across all sectors with a focus on materials innovation, industrials, nanotechnologies and semiconductors, composites, green chemistry, technical fibers, recycling, medical devices, energy, and services sectors. It seeks to invest in companies based in Europe with a focus on Lorraine, Alsace, Burgundy, Champagne-Ardenne, Franche-Comté, Wallonia, Belgium, Luxembourg, Netherlands, Saar, and Rhineland-Palatinate. It invests between €0.075 million ($0.1 million) and €2 Million ($2.65 million) in companies with sales between €3 million ($4 million) and €50 million ($66.56 million) and enterprise values up to $3.59 million. While co-investing, it can invest in transactions up to €15 million ($19.92 million). The firm prefers to take a minority stake and seeks to hold its investments for a period between five years and seven years. Groupe ILP was founded on July 1, 1983 and is based in Metz, France with an additional office in Metz, France.

Neurone Sa is a venture capital firm specializing in early to growth stage investment. The firm prefers to invest in technology companies specifically focusing in consumer technology to enterprise software and life sciences sector. The firm invest globally. Neurone Sa is based in Luxembourg, Luxembourg with additional office London, England; Milan, Italy and Nicosia, Cyprus.

NP Capital is a venture capital firm with 2 venture capital funds under management. The Early Stage Fund is focused on companies reshaping traditional markets. The Gaming-Based Services Fund I is focused on gaming industry projects including but not limited to betting, media, events, social, learning, and data analytics.

Seven2 sas is a private equity firm specializing in middle markets, later stage, carve-outs of business divisions from French or multinational corporations, public to private operations (PtoPs), and leveraged buyout in mid-caps and small and medium-sized companies. It seeks to invest in technologies, telecom, retail and consumer, media, healthcare, and business and financial services sectors. In information technology sector the firm focuses on high-tech goods and services, software technologies, hardware, emerging application segments, and services based on the mastery of new technologies. In specialized retail and consumer, it typically invests in home appliances, household goods and services, specialty retail chains, personal equipment, direct retail and e-commerce, business to business distribution, and consumer goods. In the media sector the firm seeks to invest in professional and technical publishing, broadcasting, business to business publishing, business, scientific and technical information, marketing, research, and design service companies, traditional and online, media agencies, rights, premium content and the supply of Internet content. It seeks to make investments in the telecommunications sector in segments including infrastructure and services, telecom operators, cable operators and technology companies, voice-data-video convergence, and development of new mobile services. The firm also invests in business and financial services in outsourced services focusing on financial services, business process outsourcing, services related to energy and environment. It makes investments in healthcare sectors with a focus on medical devices and services companies including private sector hospital treatment focusing on therapy of new medications or new forms for administering drugs, pharmaceutical laboratories, medical equipment, dermo-cosmetics, galenic development, and services and databases for health organizations, and health services including hospitalization structures, home health care, and medical analysis. The firm seeks to invest in companies based in French-speaking countries including France and Europe. It also invests in Turkey, Australia, Japan, South Korea, New Zealand, North Korea, Austria, Belgium, Denmark, Finland, Germany, Greece, Iceland, Italy, Belgium, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom, Czech Republic, Hungary, Poland, Slovakia, Mexico, Chile, United States and Canada. It prefers to invest in equity investment between €3.47 million ($3.79 million) and €250 million ($273.2 million) in Mid-Market €50 million ($54.65 million) and €250 million ($273.2 million) and Development: €15 million ($16.40 million) and €50 million ($54.65 million) with sales value between $13.34 million and $2732.9 million and enterprise value between $10.88 million and $1113.52 million. The firm may co-invest with others. It seeks to acquire majority or significant minority stakes and a board seat in its portfolio companies. It prefers minority position if the transaction is based on a genuine partnership with the management team, which confers them certain rights. The firm typically invests for a period of five to seven years on average. It seeks to exit its investments through trade sales, IPOs, secondary buyouts, as well as partial sales, and recaps. Seven2 sas was founded in 1972 and is based in Paris, France with additional offices in Europe.

UC Capital is a private equity and venture capital firm specializing in transformation and growth capital, buyout; special situations; either under performance, stress, distress, or right-out insolvency. The firm typically invests in small and medium size enterprises. It prefers to invest in those companies with solutions to infrastructure (solar, construction, utilities, energy), manufacturing and engineered products, advanced materials, healthcare and automotive and companies with growth opportunities. The firm primarily invests in companies based in Europe including European Union with a focus on Northern Italy, Spain, Belgium, the Netherlands and Luxembourg, Austria, Switzerland, Benelux, Southern Germany, and France, and in India. It prefers to take majority stake. The firm seeks to acquire controlling stakes and co-invests in minority positions. UC Capital is based in Barcelona, Spain with additional office in Pune, India, Catalonia, Spain, Bangalore, India and Luxembourg. As of November 10, 2016, UC Capital operates as a subsidiary of Capvent.

212 based in Istanbul, Doha, and San Francisco, invests in unique teams with global ambitions to scale B2B technology startups.

IFG Capital SA is an independent investment firm focusing on Uzbekistan and wider Central Asia. It offers a full range of business and financial advisory services as well as metals & mining expertise through its subsidiary IFG Metals & Mining. It is led by a team of professionals who combine best western practice with intimate local knowledge, operating from its head office in Luxembourg with a Central Asian regional office in Tashkent.

NMT Capital is a venture capital firm specializing in early venture, mid venture, and late venture investments. The firm primarily invests in information technology, medical technology, and life science companies with a focus on medical devices, diagnostics, advanced materials, equiptment, biotechnology, specialty pharmaceutical, life sciences, and drug discovery tools. It considers investments in the United States, Europe, the Middle East and Asia, especially in companies seeking either to expand outside their region or to attract companies into their region. The firm prefers to be the lead investor in its portfolio companies. NMT Capital was formerly known as Nexus Medical Partners. NMT Capital was founded in 2004 and is based in Norwell, Massachusetts with additional offices in Greenville, South Carolina and Luxembourg, Luxembourg.